Skip to main content
. 2021 Nov 4;39(51):7429–7440. doi: 10.1016/j.vaccine.2021.10.079

Fig. 2.

Fig. 2

Bayesian network for assessing risks versus benefits of the AstraZeneca COVID-19 vaccine.